A generic alternative indicated for Neurology. Treatment supports balanced dopamine levels in the brain to facilitate muscle control and reduce involuntary bodily movements.
A dopamine agonist formulated to manage Parkinson's symptoms and designed to alleviate restless legs syndrome to support improved motor control and rest.
Mechanism of Action
It mimics the action of dopamine by stimulating receptors in the brain's basal ganglia. This helps coordinate movement and reduces involuntary tremors.
Route of Administration
Oral
Onset Time
1–2 hours
Duration
6–24 hours (formulation dependent)
Contraindications
Allergy to ropinirole
Severe Adverse Events
Sudden sleep attacks, Hallucinations, Compulsive behaviors, Severe hypotension, Melanoma risk
Common Side Effects
Nausea, Dizziness, Drowsiness
Uncommon Side Effects
Vomiting, Fainting, Swelling in legs, Fatigue, Confusion
Information for Ropinirole is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
